MOLBIO vs BIOCON: Stock Comparison
Head-to-head financial and trading comparison between Molbio Diagnostics Limited (MOLBIO) and Biocon Limited (BIOCON) in the Cross-Sector Peers sector.
MOLBIO
NSE: MOLBIOBIOCON
NSE: BIOCONKey Metrics Comparison Table
| Metric | MOLBIO | BIOCON | Edge / Winner |
|---|---|---|---|
| Current Market Price (CMP) | ₹1,438.60 | ₹349.40 | — |
| 1-Year Price Return | +38.1% | -2.69% | MOLBIO (40.79% higher) |
| 52-Week High | ₹1,544.70 | ₹440.70 | — |
| 52-Week Low | ₹1,036.65 | ₹349.40 | — |
| 30-Day Annualized Volatility | 95.93% | 21.63% | BIOCON (Steadier) |
| 30-Day Average Daily Volume | 3,210,458 | 3,077,206 | MOLBIO (Higher Liquidity) |
| Statutory Cost to Trade ₹1 Lakh | ₹118.50 | ₹118.50 | Identical statutory tariff |
Frequently Asked Questions
Between MOLBIO and BIOCON, which stock gave better returns over the last year?
MOLBIO has outperformed BIOCON over the past 12 months with a gain of 38.1% compared to -2.69%.
Which stock is less volatile: MOLBIO or BIOCON?
BIOCON demonstrated lower price volatility (21.63% annualized) compared to MOLBIO (95.93%). Lower volatility generally indicates steadier price action during market downturns.
What is the statutory cost to buy ₹1,00,000 of MOLBIO vs BIOCON?
Statutory exchange and government charges (STT, NSE turnover fees, SEBI fee, Stamp duty, and GST) are identical for delivery purchases of equal rupee value across both stocks, totaling approximately ₹118.50 on discount brokers offering zero delivery brokerage (like Zerodha or Dhan).
Are MOLBIO and BIOCON direct sector competitors?
Yes, both companies operate within the Cross-Sector Peers sector in India and are actively tracked as sector peers by institutional and retail market participants.